If you have trouble reading this e-mail read the online version
ISSN : 2362-986X
European Commission EU eHealth in focus -
Newsletter
Strategic Report for Translational Systems Biology and Bioinformatics in the European Union
Strategic Report for Translational Systems Biology and Bioinformatics in the European Union
This white paper was prepared in order to assess the opportunities and obstacles that confront us in facilitating a translational role for bioinformatics and systems biology in drug discovery and clinical medicine. The report represents the consensus outcome of Think Tank discussions among 23 invited world-leading experts in Barcelona, Spain, on October 2011. There is potential in sub-cellular (or molecular) systems biology approaches to biomedicine, as compared to conventional methods of drug design. Despite the early stage of these approaches, and lots still to be done, they may be able to assist in more personalised approaches to drug treatment. For translational systems biology to make a major impact, the whole system of data access needs to be transformed into one based on more openness and sharing of information between hospitals, academia and industry. Various societal structures currently impede this development. Regulatory and funding agencies must be involved to overcome these obstacles.
See also : INBIOMEDVision website
Contact : info@inbiomedvision.eu
INBIOMEDvision report cover
This is the newsletter of the eHealth on Digital Agenda for Europe. It is hosted by the Digital Agenda for Europe Newsroom.

If this Newsletter was forwarded to you and you are interested to receive it directly you can subscribe here.

You may unsubscribe or broaden your subscription from this newsletter by going to Your Profile or by contacting us at this address: CNECT-EHEALTH@ec.europa.eu.